newsfilter
← Latest News
GlobeNewswire·

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ:FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the